Neumora Therapeutics, Inc. (NMRA) Tops Q1 EPS by 4c

May 13, 2025 7:05 AM EDT

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q1 EPS of ($0.42), $0.04 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK